Literature DB >> 25231588

Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.

Elisa Gabanti1, Francesca Bruno, Chiara Fornara, Stefano Bernuzzi, Daniele Lilleri, Giuseppe Gerna.   

Abstract

PURPOSE: Following primary human cytomegalovirus (HCMV) infection, both humoral and T-cell-mediated immune responses develop in immunocompetent subjects. However, while antibodies may be measured by different methodologies, the T-cell-mediated response remains to be analyzed in its polyfunctional aspects, in view of defining (following different stimuli) the optimal assay to monitor the HCMV-specific T-cell response in HCMV-seropositive subjects.
METHODS: In a group of 30 HCMV-seropositive adults, T-cell response revealed by the HCMV-infected dendritic cell (iDC) stimulus was compared with those given by the HCMV-infected cell lysate (iCL), and by a 34-peptide pool (PP).
RESULTS: All HCMV-seropositive subjects showed presence of both HCMV-specific CD4(+) and CD8(+) T-cells in peripheral blood following iDC stimulation. One subject did not respond to PP. As compared to iDC, the number of HCMV-specific stimulated T-cells/μl blood was slightly lower for iCL (P = 0.195) and significantly lower for PP (P = 0.001). Polyfunctional analysis of the T-cell response indicated that the lower number of CD4(+) T-cells stimulated by iCL was due to the bifunctional (IFN-γ(+) TNF-α(+)) and CD40L-negative T-cell reduction, while the reduction in specific PP-stimulated CD8(+) T-cells was attributable to the reduction in tri-(IFN-γ(+) TNF-α(+) IL2(+)), bi-(IFN-γ(+) TNF-α(+)) and mono-(IFN-γ(+)) functional T-cells. In addition, 15/30 (50 %) subjects showed a CD4(+) cross-response to PP, and 11/30 (37 %) a CD8(+) cross-response to iCL.
CONCLUSIONS: HCMV-specific stimulus given by iDC is not significantly different from that of iCL on CD4(+) and is significantly superior to that of PP on CD8+ T-cells. However, iCL may contribute significantly to CD8(+), and PP to CD4(+) T-cell stimulation.

Entities:  

Mesh:

Year:  2014        PMID: 25231588     DOI: 10.1007/s10875-014-0093-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  Peptide length-based prediction of peptide-MHC class II binding.

Authors:  Stewart T Chang; Debashis Ghosh; Denise E Kirschner; Jennifer J Linderman
Journal:  Bioinformatics       Date:  2006-09-25       Impact factor: 6.937

2.  Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

Authors:  Giuseppe Gerna; Elena Percivalle; Daniele Lilleri; Laura Lozza; Chiara Fornara; Gabriele Hahn; Fausto Baldanti; M Grazia Revello
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

3.  Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation.

Authors:  G Gerna; D Lilleri; C Fornara; G Comolli; L Lozza; C Campana; C Pellegrini; F Meloni; T Rampino
Journal:  Am J Transplant       Date:  2006-08-01       Impact factor: 8.086

4.  Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells.

Authors:  Laura Lozza; Daniele Lilleri; Elena Percivalle; Chiara Fornara; Giuditta Comolli; Maria Grazia Revello; Giuseppe Gerna
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

5.  Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.

Authors:  Emilia Genini; Elena Percivalle; Antonella Sarasini; M Grazia Revello; Fausto Baldanti; Giuseppe Gerna
Journal:  J Clin Virol       Date:  2011-08-04       Impact factor: 3.168

6.  Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.

Authors:  Gisela Enders; Anja Daiminger; Ursula Bäder; Simone Exler; Martin Enders
Journal:  J Clin Virol       Date:  2011-08-05       Impact factor: 3.168

7.  Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.

Authors:  H T Maecker; S A Ghanekar; M A Suni; X S He; L J Picker; V C Maino
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

8.  Passive immunization during pregnancy for congenital cytomegalovirus infection.

Authors:  Giovanni Nigro; Stuart P Adler; Renato La Torre; Al M Best
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

9.  Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Authors:  Daniele Lilleri; Anna Kabanova; Antonio Lanzavecchia; Giuseppe Gerna
Journal:  J Clin Immunol       Date:  2012-07-27       Impact factor: 8.317

10.  Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.

Authors:  Sunil Kannanganat; Chris Ibegbu; Lakshmi Chennareddi; Harriet L Robinson; Rama Rao Amara
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.